Pennsylvania House passes bill to regulate natural-leaf kratom sales

Why it matters

Pennsylvania's House vote would create consumer-facing rules for natural-leaf kratom while prohibiting synthetic derivatives, if the bill clears the Senate and is signed. The proposal illustrates a state policy approach that distinguishes product forms rather than treating all products marketed as kratom alike.

The big picture

The bill follows growing attention to products containing concentrated 7-hydroxymitragynine and other derivatives, alongside concerns about labeling, youth access, dependence and unknown drug interactions. It has not become law: it must still pass the Pennsylvania Senate and receive the governor's signature.

Key findings

• The state House unanimously passed a bill regulating sales of natural-leaf kratom products.
• The proposal would allow registered vendors to sell natural-leaf products only in powder or capsule form.
• It would prohibit sales to people under 21 and require child-resistant packaging.
• Labels would need manufacturer information, an FDA-evaluation warning and no medical claims.
• The bill would ban synthetic kratom-derived compounds and still requires Senate and gubernatorial approval.

What they say

Rep. Bridget Kosierowski said the measure aims to make the marketplace “more transparent and accountable” rather than choosing between no rules and criminalizing use.

Bottom line

The Pennsylvania House approved a regulation-and-product-distinction bill, but it remains a proposal until the state Senate and governor act.